Andrographolide demonstrates anti-proliferative activity in oral cancer by promoting apoptosis, the programmed cell death process
Objective(s): Andrographolide has been studied on different types of human cancer cells, but very few studies have been conducted on oral cancer.The study aimed to evaluate the anticancer potential of Andrographolide on an oral cancer cell line (KB) through in-silico network analysis and in vitro assays.Materials and Methods: The in-silico analysis